• Latest Posts

Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

These are our 10 Most Read Biotech Articles of 2016

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Video: Chatting with Immunocore about the Potential of Immuno-oncology

ADVERTISEMENT

UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa

It’s World AIDS Day, is Biotech close to an HIV Cure?

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

USB key Diagnostic could help manage HIV Treatment Anywhere

This has been the Worst Financial Year for Biotech in a Decade

Up, up and away! CureVac’s money pile now Totals €325M

ADVERTISEMENT